Inducing ferroptosis through GPX4 inhibition as a novel therapeutic approach for esophageal cancer

Active Project Grant Awarded Last action

Award ID
HT9425261E381
Recipient
Awarding agency
Obligated
$140,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 0% complete
Place of performance
Detroit, MI 48202, USA

Award details come from USAspending.gov.

About this award

The Defense Health Agency awarded Wayne State University $140,000 on December 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support research on inducing ferroptosis through GPX4 inhibition as a novel therapeutic approach for esophageal cancer. The award is structured as a Project Grant with a period of performance through December 14, 2028, and performance takes place in Detroit, Michigan. Wayne State University's Sponsored Project Administration Division, doing business as Wayne State University Physician Group, serves as the recipient. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative research and investigation of medical solutions for battlefield needs.

Quick answers

Who received award HT9425261E381?

HT9425261E381 was awarded to Wayne State University by Defense Health Agency (Department of Defense) on December 15, 2026.

How much is award HT9425261E381 worth?

$140,000 has been obligated on HT9425261E381.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award